Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survivorship Intervention for Patients Living With Advanced and Metastatic Cancers: a Randomized Controlled Feasibility Study

NCT06465511 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06465511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06465511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survivorship Intervention for Patients Living With Advanced and Metastatic Cancers: a Randomized Controlled Feasibility Study
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Recruiting
Start date
May 21, 2025
Completion date
December 31, 2027
Enrollment
68 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, physical symptom distress